Search Within

Neeta Pandit-Taskar

  1. "Bone Marrow Transplant"
Formats
  1. Meeting Abstract (7)
  2. Journal Article (1)
Groups
  1. Bone Marrow Transplant (8)
  2. Center for Hematologic Malignancies (8)
  3. Department of Medicine (8)
  4. Hematologic Malignancies, Division of (8)
  5. Molecular Imaging and Therapy Service (8)
  6. Radiology, Department of (8)

More Groups

People
  1. Elizabeth Hoover (3)
  2. Elyn Stubblefield (3)
  3. Hani Hassoun (3)
  4. Heather Landau (3)
  5. Raymond Comenzo (3)
  6. Stephen Nimer (3)

More People

Years
  1. 2023 (1)
  2. 2021 (1)
  3. 2019 (1)
  4. 2012 (1)
  5. 2009 (1)
  6. 2008 (1)

More Years

Publications
  1. Blood (5)
  2. Journal of Clinical Oncology (2)
  3. Leukemia and Lymphoma (1)
Publishers
  1. American Society of Hematology (5)
  2. American Society of Clinical Oncology (2)
  3. Taylor & Francis Group (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • High-dose targeted radiation with (131)I-apamistamab prior to HCT demonstrated a dose-response for durable complete remission in patients with R/R AML
    Meeting Abstract

    Litzow, M. R.; Chen, G.; Gyurkocza, B.; Nath, R.; Seropian, S.; Choe, H.; Abboud, C. N.; Koshy, N.; Tomlinson, B. K.; Abhyankar, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Iomab with adoptive cellular therapy (Iomab-ACT): A pilot study of 131-I apamistamab followed by CD19-targeted car T-cell therapy for patients with relapsed or refractory B-cell acute lymphoblastic leukemia or diffuse large B-cell lymphoma
    Meeting Abstract

    Geyer, M. B.; Cadzin, B.; Halton, E.; Kane, P.; Senechal, B.; Geoghegan, E. M.; Reddy, V.; Berger, M. S.; Ludwig, D.; Pandit-Taskar, N.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Feasibility of administering anti-CD45 iodine ((131)I) apamistamab [Iomab-B] for re-induction and targeted conditioning in older patients with active, relapsed or refractory AML without lead-lined rooms: SIERRA trial experience at MSKCC
    Meeting Abstract

    Chu, B. P.; Pandit-Taskar, N.; Gyurkocza, B.; Liang, Q.; Miodownik, D.; Reddy, V.; Berger, M. S.; Dauer, L. T.
    Blood (2019)

    Fulltext@MSK | Save
  • Bortezomib, liposomal doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective treatment for patients with newly diagnosed multiple myeloma with Internatinal Staging System stage II or III, or extramedullary disease
    Journal Article

    Landau, H.; Pandit-Taskar, N.; Hassoun, H.; Cohen, A.; Lesokhin, A.; Lendvai, N.; Drullinsky, P.; Schulman, P.; Jhanwar, S.; Hoover, E.; more...
    Leukemia and Lymphoma (2012)

    Fulltext@MSK | Save
  • FDG PET/CT (FDG PET) in evaluation of response in patients with multiple myeloma (MM) treated with bortezomib, pegylated liposomal doxorubicin, and dexamethasone
    Meeting Abstract

    Pandit-Taskar, N.; Comenzo, R. L.; Hassoun, H.; Hoover, E.; Borkar, S.; Reidel, E.; Cohen, A.; Surti, C.; Nimer, S. D.; Landau, H. J.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Sequential administration of bortezomib, liposomal doxorubicin and dexamethasone (BDD) followed by thalidomide and dexamethasone (TD) results in rapid control of untreated high-risk multiple myeloma (MM) and improves depth of response
    Meeting Abstract

    Landau, H.; Hassoun, H.; Cohen, A.; Hoover, E.; Kewalramani, T.; Boruchov, A.; Klimek, V.; Reich, L.; Riedel, E.; Pandit-Taskar, N.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Sequential radioimmunotherapy with tositumomab/iodine I131 tositumomab followed by CHOP for mantle cell lymphoma demonstrates RIT can induce molecular remissions
    Meeting Abstract

    Zelenetz, A. D.; Noy, A.; Pandit-Taskar, N.; Scordo, M.; Rijo, I.; Zhou, Y.; O'Donoghue, J. A.; Divgi, C.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Frequency of molecular and PET/CT complete remissions in patients with multiple myeloma after autologous followed by reduced-intensity allogeneic stem cell transplants
    Meeting Abstract

    Zhou, P.; Castro-Malaspina, H.; Papadopoulos, E. B.; Young, J. W.; Miller, K.; Pandit-Taskar, N.; Filippa, D. A.; Fleisher, M.; Comenzo, R. L.
    Blood (2004)

    Fulltext@MSK | Save